Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells.
about
Regeneration of stalled immune responses to transformed and infected cells using γδ T cellsSix-of-the-best: unique contributions of γδ T cells to immunologyγδ T cells for cancer immunotherapy: A systematic review of clinical trialsγδ T cells in cancer immunotherapyAge dependent differences in the kinetics of γδ T cells after influenza vaccination.Expanded Human Blood-Derived γδT Cells Display Potent Antigen-Presentation Functions.Activating and propagating polyclonal gamma delta T cells with broad specificity for malignanciesPlasticity of γδ T Cells: Impact on the Anti-Tumor ResponseClinical applications of gamma delta T cells with multivalent immunity.Adoptive T-cell therapy for cancer in the United kingdom: a review of activity for the British Society of Gene and Cell Therapy annual meeting 2015.Neuroblastoma killing properties of Vδ2 and Vδ2-negative γδT cells following expansion by artificial antigen-presenting cells.In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells.Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells.Frequent Malaria Drives Progressive Vδ2 T-Cell Loss, Dysfunction, and CD16 Up-regulation During Early Childhood.Human γδ T cells augment antigen presentation in Listeria Monocytogenes infection.Co-expression of CD40L with CD70 or OX40L increases B-cell viability and antitumor efficacy.Tumor-activated TCRγδ⁺ T cells from gastric cancer patients induce the antitumor immune response of TCRαβ⁺ T cells via their antigen-presenting cell-like effects.Licensing of killer dendritic cells in mouse and humans: functional similarities between IKDC and human blood γδ T-lymphocytes.The multifunctionality of human Vγ9Vδ2 γδ T cells: clonal plasticity or distinct subsets?Role of gamma-delta T-cells in cancer: another opening door to immunotherapy.Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.Gammadelta T cells: innately adaptive immune cells?Potential Use of γδ T Cell-Based Vaccines in Cancer Immunotherapy.Cancer Immunotherapy Using γδT Cells: Dealing with Diversity.Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy.The Jekyll and Hyde story of IL17-Producing γδT Cells.E. coli promotes human Vγ9Vδ2 T cell transition from cytokine-producing bactericidal effectors to professional phagocytic killers in a TCR-dependent manner.Mycobacterium-Specific γ9δ2 T Cells Mediate Both Pathogen-Inhibitory and CD40 Ligand-Dependent Antigen Presentation Effects Important for Tuberculosis Immunity.Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity.Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cellsCombination strategies to enhance the potency of monocyte-derived dendritic cell-based cancer vaccines.Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.Immunosurveillance by human γδ T lymphocytes: the emerging role of butyrophilins.Non-V delta 2 gamma delta T lymphocytes as effectors of cancer immunotherapy.Association between peripheral γδ T cell subsets and disease progression of severe fever with thrombocytopenia syndrome virus infection.Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cells.Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab.Editorial: "Recent Advances in Gamma/Delta T Cell Biology: New Ligands, New Functions, and New Translational Perspectives".Licensing of γδT cells for professional antigen presentation: A new role for antibodies in regulation of antitumor immune responses.γ/δ T cell subsets in human aging using the classical α/β T cell model.
P2860
Q26823185-0E5CF061-22B4-4888-B745-F70674051A37Q27010451-E1A31925-A31C-4CC7-9B91-E4D906D27C43Q27021705-0DF76B0C-34EE-4AB9-A195-556C2A9EB28DQ28068988-A52D54D5-5F81-4DB6-8B76-B80DB61D9252Q33898222-8CC25B47-34D8-40A0-AEFF-458917E19F9CQ33938500-8B63233D-89FF-4941-86F0-32CDAA391CE7Q34517192-A490ECC7-0C6C-4D4E-A387-92DD246155F8Q34652408-FB99E677-2075-4089-87C7-51D796EEA0D4Q34677859-53D1B90F-376F-4806-9023-1127433579E1Q35641721-DF875A6E-75DB-4017-A8D0-DEC29B2488DDQ35654544-157A3F1F-39C9-419B-8B0B-6FE47E1E65D4Q35803534-21FCCE7C-DEDD-4F7B-8EF1-251DF6AC3E06Q36597374-48C70D6F-D94F-4C5C-ADA6-7A2DBEB50CFFQ36745233-84555B5F-5962-4866-A450-1989DDF8E2C0Q37541036-E7781DB4-5E49-4122-9E5C-6FAF0EE466F8Q37564683-AD8334AB-CD59-4898-9697-24606168B550Q37706085-BA544574-D07B-4EEB-BDD2-B7E5C68A03B1Q38013197-73F269B1-B6D1-4126-97C7-982F4E70B004Q38016451-54150C3E-2A97-44F8-B3E8-3B5B9CF75436Q38051222-61465F61-AD6E-4931-949A-F5CBCD35F0EAQ38051730-E8EC81A5-9322-4F45-A540-33AFB7F9AEE0Q38101588-F3856D5C-5D5B-40C0-ADA0-EC29E13A8388Q38265506-D19A39AA-08B7-4F6D-A5D0-25A4BB5DCD03Q38283536-3EB3E75D-ECCC-46F1-854E-1603A26BFDD0Q38310258-A2E65823-3141-44AC-811A-BCD6DDA34D72Q38362640-2ECAFD4B-9177-4BD3-80DF-BCBE53839376Q38742060-F81F0FC3-402C-41FE-B697-3837576FA1ECQ38813812-E924CE81-6851-4197-BF4D-2AE7DFB7F2F8Q38883322-83D4023E-AE86-497E-A4F6-DB4AC71CCBDFQ38934681-99898281-2A00-4F5E-BB5A-E80F71389848Q38948897-109A099A-F230-448E-A783-348284EB6FF8Q39396311-A9B0BBFA-3D1D-469A-84CC-B8A6DC89C2EBQ39397758-56A9B2E1-0073-4226-945A-6E0FEB5977A6Q39832849-26F7C8C8-EFF0-4A5A-874B-F5D651A42E7AQ40041163-76DE8250-7873-47F4-81C1-6173F1D5325BQ40267794-E4F7BC8F-BAE9-4091-A5DF-8043985EA619Q40355238-8A7411BC-3200-4C82-8414-FB55727B9057Q41061926-6A70C796-D5A0-439F-BBC7-6228057F5EA9Q42051531-86186191-4D65-4C7D-8BD6-C0A8E5186446Q42207622-DE6B5DE6-F801-4C3E-94E3-93329B6844FA
P2860
Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Human γδ T lymphocytes are lic ...... n with opsonized target cells.
@en
Human γδ T lymphocytes are lic ...... n with opsonized target cells.
@nl
type
label
Human γδ T lymphocytes are lic ...... n with opsonized target cells.
@en
Human γδ T lymphocytes are lic ...... n with opsonized target cells.
@nl
prefLabel
Human γδ T lymphocytes are lic ...... n with opsonized target cells.
@en
Human γδ T lymphocytes are lic ...... n with opsonized target cells.
@nl
P2093
P356
P1476
Human γδ T lymphocytes are lic ...... n with opsonized target cells.
@en
P2093
Cyrille J Cohen
John Anderson
Kenth Gustafsson
Luisa Saraiva
Mengyong Yan
Nourredine Himoudi
P304
P356
10.4049/JIMMUNOL.1102654
P407
P577
2012-01-16T00:00:00Z